Certified by Founder
Lodge
Nelly Solutions
start up
Germany
- Berlin
- 15/01/2025
- Series B
- $51,555,959
Nelly is a cutting-edge healthcare payments company, revolutionizing medical practice workflows with its patient check-in and check-out software. Our dynamic team of industry experts has a passion for tech- and data-driven innovation and is dedicated to providing efficient solutions. We are well-financed with 20M in venture capital from world-class investors such as Lakestar, GFC, b2venture, and Motive Partners.
- Industry Financial Services
- Website https://www.getnelly.de/en
- LinkedIn https://www.linkedin.com/company/nelly-solutions/
Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)